Gilead Sciences, Inc. (GILD)

Gilead Sciences Revenue

Gilead Sciences had revenue of $7.77B in the quarter ending September 30, 2025, with 2.97% growth. This brings the company's revenue in the last twelve months to $29.09B, up 2.78% year-over-year. In the year 2024, Gilead Sciences had annual revenue of $28.75B with 6.04% growth.

• Revenue (ttm): $29.09B
• Revenue Growth: +2.78%
• P/S Ratio: 6.53
• Revenue / Employee: $1,652,670
• Employees: 17,600
• Market Cap: 189.20B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	28.75B	1.64B	6.04%
Dec 31, 2023	27.12B	-165.00M	-0.60%
Dec 31, 2022	27.28B	-24.00M	-0.09%
Dec 31, 2021	27.31B	2.62B	10.60%
Dec 31, 2020	24.69B	2.24B	9.98%
Dec 31, 2019	22.45B	322.00M	1.46%
Dec 31, 2018	22.13B	-3.98B	-15.24%
Dec 31, 2017	26.11B	-4.28B	-14.09%
Dec 31, 2016	30.39B	-2.25B	-6.89%
Dec 31, 2015	32.64B	7.75B	31.13%
Dec 31, 2014	24.89B	13.69B	122.19%
Dec 31, 2013	11.20B	1.50B	15.46%
Dec 31, 2012	9.70B	1.32B	15.70%
Dec 31, 2011	8.39B	435.97M	5.48%
Dec 31, 2010	7.95B	938.04M	13.38%
Dec 31, 2009	7.01B	1.68B	31.40%
Dec 31, 2008	5.34B	1.11B	26.14%
Dec 31, 2007	4.23B	1.20B	39.78%
Dec 31, 2006	3.03B	997.74M	49.19%
Dec 31, 2005	2.03B	-	-